ISRG vs WST — Key Metrics

Metric ISRG (INTUITIVE SURGICAL INC) WST (WEST PHARMACEUTICAL SERVICES INC)
Price420.95404.02
Market Cap145.92 Billion28.14 Billion
P/E (TTM)50.4145.04
P/B (Quarterly)9.2839.779
P/S (TTM)12.68.29
Net Profit Margin (TTM)25.518.8
Gross Margin (TTM)67.237.6
ROE (TTM)17.021.1
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

INTUITIVE SURGICAL INC
vs
 
WEST PHARMACEUTICAL SERVICES INC
 
INTUITIVE SURGICAL INC
vs
 
WEST PHARMACEUTICAL SERVICES INC
Performance Comparison
AI Model Recommendation
ISRG · INTUITIVE SURGICAL INC

Outperform

28
UnderperformOutperform
WST · WEST PHARMACEUTICAL SERVICES INC

Greatly Underperform

-95
UnderperformOutperform
Recommendation Summary

Stock ISRG is projected to outperform the market, stock WST is projected to greatly underperform the market. Upfront Recommendation: ISRG.

Financial Metrics
Prices delayed ~15 min
ISRG Metrics WST
$420.95 Price $404.02
— Market Capitalization —
50.41 Price to Earnings Ratio 45.04
12.6 Price to Sales 8.29
40.04 Price to FCF Ratio 48.5
18.76 Price to Gross Profit 22.04
97.69 Price to R&D 372.28
17.31 Price to Current Assets 15.49

ISRG vs WST at a glance

Intuitive Surgical INC (ISRG) and West Pharmaceutical Services INC (WST) are both Medical Instruments & Supplies companies in the Healthcare sector. ISRG is the larger, at $145.9 billion in market value against $28.1 billion for WST, about 5.2 times the size.

On trailing-twelve-month figures, ISRG trades at 50.4 times trailing earnings and WST at 45.0; net profit margins are 25.5% and 18.8%.

The Upfront Investment model currently rates ISRG Outperform and WST Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.